May 4, 2018 / 6:35 AM / in 2 months

BRIEF-Cantargia's European Patents For Both Leukemia And Solid Tumours Remain Valid After Appeal Period Ends

Cantargia AB:

* CANTARGIA’S EUROPEAN PATENTS FOR BOTH LEUKEMIA AND SOLID TUMOURS REMAIN VALID AFTER APPEAL PERIOD ENDS

* CO’S EUROPEAN PATENTS COVERING ANTIBODY TREATMENT OF LEUKEMIA AS WELL AS SOLID TUMOURS WILL REMAIN IN FORCE BASED ON EPO COMMUNICATION Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below